PuSH - Publikationsserver des Helmholtz Zentrums München

Casas, A.I.* ; Kleikers, P.W.M.* ; Geuss, E.* ; Langhauser, F.* ; Adler, T. ; Busch, D.H.* ; Gailus-Durner, V. ; Hrabě de Angelis, M. ; Egea, J.* ; Lopez, M.G.* ; Kleinschnitz, C.* ; Schmidt, H.H.H.W.*

Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke.

J. Clin. Invest. 129, 1772-1778 (2019)
Verlagsversion Preprint Forschungsdaten DOI PMC
Open Access Gold
lschemic stroke is a predominant cause of disability worldwide, with thrombolytic or mechanical removal of the occlusion being the only therapeutic option. Reperfusion bears the risk of an acute deleterious calcium-dependent breakdown of the blood-brain barrier. Its mechanism, however, is unknown. Here, we identified type 5 NADPH oxidase (NOX5), a calciumactivated, ROS-forming enzyme, as the missing link. Using a humanized knockin (KI) mouse model and in vitro organotypic cultures, we found that reoxygenation or calcium overload increased brain ROS levels in a NOX5-dependent manner. In vivo, postischemic ROS formation, infarct volume, and functional outcomes were worsened in NOXS-KI mice. Of clinical and therapeutic relevance, in a human blood-barrier model, pharmacological NOX inhibition also prevented acute reoxygenationinduced leakage. Our data support further evaluation of poststroke recanalization in the presence of NOX inhibition for limiting stroke-induced damage.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
12.282
2.462
23
41
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Calcium ; Hypoxia ; Neuroscience ; Pharmacology ; Therapeutics; Nadph Oxidase; Independent Predictor; Therapeutic Targets; Neuroprotection; Angiogenesis; Injury; Count
Sprache englisch
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 0021-9738
e-ISSN 1558-8238
Quellenangaben Band: 129, Heft: 4, Seiten: 1772-1778 Artikelnummer: , Supplement: ,
Verlag American Society of Clinical Investigation
Verlagsort 2015 Manchester Rd, Ann Arbor, Mi 48104 Usa
Begutachtungsstatus Peer reviewed
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-500600-001
Scopus ID 85063256759
PubMed ID 30882367
Erfassungsdatum 2019-03-25